The unstoppable march of genomics into clinical practice continues. In an ideal world, the expanding use of genomic tools will identify disease before the onset of clinical symptoms and determine individualized drug treatment leading to precision medicine. However, many challenges remain for the successful translation of genomic knowledge and technologies into health advances and actionable patient care.
Join vital discussions of the applications, questions and solutions surrounding clinical genome analysis.
Topics Include:
- Working with the Payer Process
- Genome Variation and Clinical Utility
- NGS Is Guiding Therapies
- NGS Is Redefining Genomics
- Interpretation and Translation to the Client
- Integrating Genomic Data into the Clinic
Keynote Speakers
 Atul Butte, M.D., Ph.D.
Division Chief and Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children’s Hospital
|
 David Galas, Ph.D.
Principal Scientist, Pacific Northwest Diabetes Research Institute
|
 Gail P. Jarvik, M.D., Ph.D.
Head, Division of Medical Genetics, Arno G. Motulsky Endowed Chair in Medicine and Professor, Medicine and Genome Sciences, University of Washington Medical Center
|
 John Pfeifer, M.D., Ph.D.
Vice Chair, Clinical Affairs, Pathology and Immunology; Professor, Pathology and Immunology, Washington University
|
 John Quackenbush, Ph.D.
Professor, Dana-Farber Cancer Institute and Harvard School of Public Health; Co-Founder and CEO, GenoSpace
|